Caudex Medical appoints two new staff members

Caudex Medical has bolstered its team with the appointment of two new members of staff in senior positions.

Andy Bowman has been appointed global head of Caudex Medical, while Gary Burd will join the communications agency in the role of director of scientific services, reports InPharm.

Mr Bowman has been appointed from Choice Group, having served as chief executive of Choice Healthcare Solutions and vice-chairman of the organisation as a whole, and offers more than 20 years of pharmaceutical and agency experience.

Meanwhile, Mr Burd's former roles include five years with Complete HealthVizion and three years at Parexel, offering expertise in fields such as oncology, rheumatoid arthritis, multiple sclerosis and diabetes.

He will be tasked with aiding the development of Caudex's service offering and innovation.

Caudex Medical currently employs more than 85 people across its operations in the UK and US, offering strategic consultancy and communication expertise across a range of areas.